E. F. Bostwick

Bovine immunoglobulin concentrate-Clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestine

C. Pothoulakis, C. Kelly, A. Fatimi, 1999, Gut.

Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract

C. Pothoulakis, C. Kelly, S. Keates, 1997, Antimicrobial agents and chemotherapy.

Bioactive proteins and probiotic bacteria: modulators of nutritional health.

R. Hoerr, E. Bostwick, E. F. Bostwick, 2000, Nutrition.

Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge.

C. Tacket, G. Losonsky, R. Edelman, 1992, The American journal of tropical medicine and hygiene.

Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate

S. Binion, T. Wilkins, D. Lyerly, 1991, Infection and immunity.

In vitro and in vivo effects of the probiotic Escherichia coli strain M-17: immunomodulation and attenuation of murine colitis

R. Hoerr, W. Koltun, L. Fitzpatrick, 2008, British Journal of Nutrition.

Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C. difficile toxins

C. Pothoulakis, C. Kelly, S. Keates, 1996, Antimicrobial agents and chemotherapy.

Negative feedback control of bovine serum luteinizing hormone (LH) concentration from completion of the preovulatory LH surge until resumption of luteal function.

T. Beck, E. Convey, H. Hafs, 1977, Journal of animal science.